Launching global clinical trials is overwhelming every region demands unique compliance, submissions, and approval timelines. Having worked with diverse regulatory bodies (DCGI, FDA, EMA), we know how critical early readiness is. This guide gives you a clear comparison of India,…
The world continues to feel the ripple effects of the COVID-19 pandemic, even into 2025. While vaccines, therapeutics, and preventive measures have significantly reduced the global burden of the disease, the healthcare industry is still adapting to the disruptions and…
Elevate your herbal brand by embracing clinical trials—uncover how scientifically backed validation can transform herbal products into trusted, market-leading solutions Abstract The herbal product industry is undergoing a transformative shift as companies increasingly integrate clinical trials to validate the safety…
Integrating E-Clinical Technologies in smarter clinical trials improves efficiency, enhances data accuracy, and streamlines clinical research for better patient outcomes. With the increasing world population, clinical trials are now more sophisticated and difficult exciting integration of E- clinical technologies to…
Patients are the heart of all clinical trials ranging from recruitment, retention, protocol adherence, assessments, and safety data, making it necessary to ensure that patients arewell-informed on trial protocol, conduct, and patients’ rights. Various measures are in place such as…
Although time, speed, and operational constraints have long plagued the progress of clinical trials, another factor that remains important and has been gaining prime importance as the centre of clinical trials is the patient. It has been shown that patient…
In the United States, The Food and Drug Administration (FDA) regulates and oversees clinical trials of food and dietary supplements and develops various regulations and guidelines for their use. The FDA defines ‘food’ as per the Food, Drug, and Cosmetic…
With a population of approximately 1.4 billion people, healthcare expenditure of 2.6% of the country’s gross domestic product (GDP), and the presence of several multinational pharmaceutical and biopharmaceutical companies in India are some factors that have led to India being…
According to the National Cancer Institute (NCI), a solid tumour is a mass of tissue that usually does not contain cysts or liquid areas such as sarcomas (arising from connective tissue), lymphoma (arising from the lymphatic system), and carcinomas (arising…
Despite advancements in digitization and remote or decentralized trials, traditional clinical trials with a central site, in-person recruitment and monitoring, and paper-based or electronic regulatory submissions continue to remain critical for the approval of new drugs, medical devices, and biologicals.…
Be the first to know the latest trends in clinical research, real-world case studies, and industry secrets.
ProRelix Research is the rapidly growing Contract/ Clinical Research Organization (CRO) with multi-country service capability supporting phase 1, 2, 3, & 4 clinical trials of Pharma, Biotech, Biopharma, Medical Device, Nutraceutical & Herbal companies to conduct in the USA, India, Europe & South East Asia.